You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Guatemala

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Guatemala with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Guatemala, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Guatemala for free:

The Consumer Health in Guatemala market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Guatemala?
  • What are the major brands in Guatemala?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Improved results after economic recovery

In 2009, consumer health sales were hindered because of the local effects of the global economic and financial crisis. Many products in the healthcare market are not regarded as staples, and lost out to consumption of more essential goods. Sales in 2010 showed an improvement, however. However, the increased importance of low priced generic products had an effect in terms of limiting value sales. Many companies have focused on increasing their sales among their existing consumer base, while others are focusing on widening the consumer base in order to ensure future growth.

Urbanisation and modernisation impact consumption habits

With more of the population living in urban areas, the lifestyles of many Guatemalans have changed. People who used to eat at home every day now eat out more often, more women and young adults are working, and lifestyles in general are more competitive and fast moving. This change in lifestyles opens opportunities for certain consumer health categories. Urbanisation and modernisation are impacting consumption habits, as consumers are increasingly willing to use consumer health products for their specific needs. Greater knowledge and increased offerings have helped the performance of various categories, such as digestive remedies, vitamins and dietary supplements, and cough, cold and allergy (hay fever) remedies. Consumers are now looking for products that alleviate their symptoms quickly, without significant side effects. Formulas with energy boosters are popular, since most consumers can no longer afford to stay at home while they recover, but need to keep working while they get better.

Generic brands act as a stepping stone

Because a high percentage of the Guatemalan population live in poverty, generic brands are playing an important role in the expansion of the consumer health market in Guatemala. These brands have been able to increase their availability significantly because of commercialisation through economy pharmacy chains, which are rapidly expanding in the country. Consumers who need to consume medicines but have limited budgets are opting first to buy generic products. With rising disposable incomes, consumers who purchase generics can then upgrade to branded options, which may better meet their specific needs.

Modern and chained outlets dominate distribution

Although the traditional pharmacy channel still plays an important role in the distribution of consumer health products in Guatemala, modern outlets are gaining increasing importance in the country. Chained outlets are performing well, as these can enjoy of economies of scale gained by greater efficiency in distribution, marketing and advertising. These new chained outlets, which have taken the place of individually-owned chemists/pharmacies, attract more customers thanks to the wider range of products that they offer. Additionally, these chains offer supplementary services, such as tests for glucose and cholesterol levels. Chained outlets are preferred because of their convenience for one-stop purchases, with products ranging from medicines, to beauty and personal care, and even to groceries in some cases.

Poverty in Guatemala hinders growth

Around 50% of the Guatemalan population still lives in poverty. Although the current consumer base for consumer health has increased, and higher disposable incomes have enabled companies to generate increased purchases among consumers, growth in the market is still forecast to be moderate. The increased importance of generic brands is expected to have an impact on value, pushing prices down. However, the lower prices of generic products will be balanced out by the higher prices of more specialised/customised branded options, which consumers with higher purchasing power will favour.

Table of Contents

Table of Contents

Consumer Health in Guatemala - Industry Overview

EXECUTIVE SUMMARY

Improved results after economic recovery

Urbanisation and modernisation impact consumption habits

Generic brands act as a stepping stone

Modern and chained outlets dominate distribution

Poverty in Guatemala hinders growth

KEY TRENDS AND DEVELOPMENTS

Economic deficiencies among non-consumers hinder growth

Product segmentation a key to success

Opportunities lie in demographics and changing lifestyles

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares 2006-2010
  • Table 6 Consumer Health Brand Shares 2007-2010
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Guatemala - Company Profiles

Corp Lancasco SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Corporación Lancasco SA: Competitive Position 2010

Farmamédica SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Farmamédica SA: Competitive Position 2010

Laboratorios Laprin SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Laboratorios Laprin SA: Competitive Position 2010

Adult Mouth Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care is one of the smallest categories in the consumer health industry in Guatemala. In 2010, sales reached a value of GTQ192,600, after experiencing 4% current value growth in that year. There are many products within the mouth care category that are only available UTC or Rx, making OTC sales almost non-existent.

SWITCHES

COMPETITIVE LANDSCAPE

  • There are no major brands in adult mouth care in Guatemala, other than Pyralvex by Laboratorios Berna, which is used to treat mouth ulcers. However, this product is frequently only available behind the counter and not available OTC.

PROSPECTS

  • Adult mouth care is expected to grow at a 2% constant value CAGR between 2010 and 2015, to reach a value of almost GTQ210,000 at constant 2010 prices. Per capita consumption will remain negligible on a national level, especially since consumers mostly purchase these products UTC or Rx, since OTC availability is limited. Also, a lack of awareness about how to treat mouth ailments will continue to hinder growth in the category.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2005-2010
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 13 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 14 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2009, analgesics sales reached GTQ98 million, after experiencing current terms value growth of 8%. Analgesics represent 19% of the entire consumer health market in Guatemala. These products are commonly consumed without prescription. Their consumption has been boosted by consistent advertising and promotions carried out by the most important brands.

SWITCHES

COMPETITIVE LANDSCAPE

  • Generic products lead the category, holding a value share of 28% in 2010. Bayer de Centroamérica y El Caribe is the leading branded manufacturer, with a share of 27%. Bayer has been present with its different brands in the market for a long time. The company has been very active in terms of advertising and, most importantly, innovation. Bayer endeavours to keep consumers interested in its brands through the launch of different products that are increasingly segmented to target specific market niches. The company is also very active in terms of advertising and promotion of its already well-known products.

PROSPECTS

  • The analgesics category is predicted to experience a 3% constant value CAGR over the forecast period, to reach sales of GTQ114 million at constant 2010 prices by 2015. Sales of this category in the future will benefit from consistent advertising and promotional efforts by the most important market players. These companies will continue to innovate and further segment their offerings, targeting specific niches of the market, as well as diversifying in terms of use of their medicines and/or target groups for their products. Sales of the category will also be boosted by the increased role of generic brands, which will continue to make this type of product available to a wider group of consumers.

CATEGORY DATA

  • Table 15 Sales of Analgesics by Category: Value 2005-2010
  • Table 16 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 17 Analgesics Company Shares 2006-2010
  • Table 18 Analgesics Brand Shares 2007-2010
  • Table 19 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 20 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Sales in the calming and sleeping category in Guatemala stood at GTQ830,500 in 2010. This represented an increase of 3% on the previous year. This is one of the smaller categories in the consumer health market in Guatemala. Consumption of this type of products is often regarded as dangerous, since they might cause addiction in some cases. For this reason, consumers generally seek professional advice prior to purchasing this type of product.

SWITCHES

COMPETITIVE LANDSCAPE

  • The calming and sleeping category is very fragmented, with a number of small brands having some participation in the market for these products. Among the most notable companies are Bayer, Infasa and Laboratorios Homeopáticos Nartex SA de CV, which offer popular calming and sleeping products. However, overall, the category remains fragmented.

PROSPECTS

  • The calming and sleeping category is expected to reach value sales of just over GTQ88,000 at constant 2010 prices by 2015, after growing by an annual average of 2% in constant value terms over the forecast period. Growth will be hindered by competition from UTC and Rx products, and reluctance among consumers to take this type of product.

CATEGORY DATA

  • Table 21 Sales of Calming and Sleeping: Value 2005-2010
  • Table 22 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 23 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 24 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala - Category Analysis

HEADLINES

TRENDS

  • The cough, cold and allergy (hay fever) remedies category grew by 9% in 2010, to reach value sales of GTQ97 million, thus accounting for around 19% of the total consumer health market in the country. Consumption of these products is favoured by the weather in Guatemala, with a rainy season which usually lasts from May to October. During this season, people who have a susceptibility to allergies often need to take cough, cold and allergy (hay fever) remedies in order to alleviate their symptoms. During this season it is also more common to suffer from coughs or colds. Combination products continue to be the most popular type, accounting for around 50% of total value sales in 2010. These products are preferred, as they help alleviate multiple symptoms caused by these ailments.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Centroamérica y El Caribe leads the category, with a 16% value share in 2010. The company is present with just one brand, Tabcin. Bayer owes its leading position to its long presence in the market, and continuous efforts in terms of innovation, marketing and advertising. However, in general terms, generics are the true leaders of the cough, cold and allergy category in the country. Generics accounted for a 24% share of value sales in 2010. These products have gained importance as their distribution increases, especially in pharmacies that specialise in the commercialisation of this type of product, such as Farmacias de la Comunidad and Farmacias del Dr Simi.

PROSPECTS

  • A 4% constant value CAGR is predicted over the forecast period, with sales reaching GTQ115 million at constant 2010 prices by 2015. This category will continue to contribute strongly to sales of the OTC category, accounting for almost 33% of total value sales in 2015, and 19% of the wider consumer health market. Sales of cough, cold and allergy (hay fever) remedies will benefit from growth in self-medication, as well as innovation, especially in combination formats, which will continue to gain in popularity.

CATEGORY DATA

  • Table 25 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 26 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2006-2010
  • Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2007-2010
  • Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Guatemala - Category Analysis

HEADLINES

TRENDS

  • The digestive remedies category in Guatemala was valued at GTQ41 million in 2010, after experiencing current value growth of 13% in that year. Sales in this category are boosted by poor eating habits, stress and low sanitary conditions, especially due to poor water quality, which causes a lot of health issues affecting the digestive system directly, particularly in the provinces. Antacids and diarrhoeal remedies together accounted for 87% of total value sales in 2010. Given the socioeconomic conditions of the country, a large percentage of the population is not able to afford medicines. For this reason, the government has implemented plans to distribute medicines to treat digestive illnesses. In October 2010, the government announced that it will distribute zinc-based pills to fight digestive ailments. The poverty of Guatemala is a significant impediment to further growth in the digestive remedies and other categories of the consumer health market in the country.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Centroamérica y El Caribe leads this category, with 25% of total value sales in 2010. Generics as a whole ranked number two in the category, as their lower prices encourage consumers to prefer these products to branded medicines. GlaxoSmithKline Guatemala and Procter & Gamble Interamericas de Guatemala Ltd, followed in the rankings, with value shares of 18% and 10%, respectively. The brands Alka Seltzer (Bayer), Sal Andrews (GlaxoSmithKline) and Pepto-Bismol (Procter & Gamble) accounted for 18%, 9% and 9%, respectively, of value sales in 2010.

PROSPECTS

  • The digestive remedies category is predicted to reach a value of GTQ52 million at constant 2010 prices by 2015, after experiencing a 5% constant value CAGR over the forecast period. Almost 80% of value sales in 2015 are expected to be accounted for by indigestion and heartburn remedies. These products are popular, since they can be used to treat several symptoms with one dose. Many consumers use such products on a daily basis, in order to avoid chronic discomfort while eating.

CATEGORY DATA

  • Table 31 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 32 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 33 Digestive Remedies Company Shares 2006-2010
  • Table 34 Digestive Remedies Brand Shares 2007-2010
  • Table 35 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 36 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Value sales in the ear care category in Guatemala increased by 7% in 2010, to reach GTQ1 million. The category is one of the smallest in the consumer health market, with few OTC products available. Most people seek professional advice prior to purchasing ear care products in the country.

SWITCHES

COMPETITIVE LANDSCAPE

  • The competitive landscape of ear care in Guatemala is fragmented between a number of small players. The small size of this category of the consumer healthcare market deters players from entering the market.

PROSPECTS

  • The ear care category is expected to show a steady performance over the forecast period, growing at a CAGR of 3% in constant value terms, to reach almost GTQ2 million at constant 2010 prices by 2015. Growth in this category will mainly be driven by growth in the population, greater health awareness and higher disposable incomes among the Guatemalan population. Price increases are expected to remain minimal, as manufacturers endeavour to boost volume sales.

CATEGORY DATA

  • Table 37 Sales of Ear Care: Value 2005-2010
  • Table 38 Sales of Ear Care: % Value Growth 2005-2010
  • Table 39 Forecast Sales of Ear Care: Value 2010-2015
  • Table 40 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • The eye care category in Guatemala amounted to only around GTQ1 million in value terms in 2010, having grown by 8% in that year. Sales in this category are expected to continue growing because of the rising incidence of eye-related illnesses, caused in particular by increased pollution. Changes in consumer preferences have also helped growth in the category, with more people wearing contact lenses and thus requiring the accompanying eye care products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer Guatemala SA leads eye care sales, with 32% of value in 2010. GlaxoSmithKline follows, with a 23% share of value sales. These companies have long been present with their brands Visina and EyeMo II, respectively, which have gained strong recognition and a good positioning in OTC sales.

PROSPECTS

  • Value sales of eye care are predicted to grow at a constant value CAGR of 3% between 2010 and 2015, to reach almost GTQ2 million at constant 2010 prices. Increased urbanisation in the country will help to boost sales, with more pollution and a consequent higher incidence of eye ailments.

CATEGORY DATA

  • Table 41 Sales of Eye Care by Category: Value 2005-2010
  • Table 42 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 43 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 44 Eye Care Company Shares 2006-2010
  • Table 45 Eye Care Brand Shares 2007-2010
  • Table 46 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 47 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2009, the herbal/traditional products category experienced current value growth of 18%, to reach sales of GTQ30 million. Herbal cough, cold and allergy (hay fever) remedies together with herbal/traditional vitamins and dietary supplements dominate the category, accounting for 81% of total value sales. Herbal products continue to be popular among mainstream consumers, but are mostly found unpackaged and sold informally. However, within consumer health products as defined in this report, consumers mostly rely on standard options. These are commonly thought of as more effective, and are also more widely recommended by health specialists.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products is still an emerging category. Manufacturers have made little effort to create significant brand awareness, thus the category remains highly fragmented in Guatemala.

PROSPECTS

  • Over the forecast period, the herbal/traditional products category is predicted to experience a 7% constant value CAGR, to reach GTQ43 million at constant 2010 prices. Sales are expected to continue to be dominated by dietary supplements and cough, cold and allergy (hay fever) remedies, accounting for 47% and 37% of total sales, respectively, in 2015.

CATEGORY DATA

  • Table 48 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 49 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 50 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 51 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In Guatemala, the medicated skin care category amounted to GTQ48 million in 2010, up by 10% in current value terms over the year. Acne treatments is the most important category, accounting for 72% of total sales of medicated skin care in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alfredo Herbruger Jr & Co Ltda leads the medicated skin care category, accounting for 30% of total value sales in 2010, thanks to its leading position in acne treatments. Avon Guatemala SA and Schering-Plough SA de CV follow, with 15% and 8% shares of value sales, respectively. Avon’s position is due to its brand Clearskin and its strong position in the acne treatment category. Schering-Plough holds third position thanks to its topical antifungals, which have been present in the market for a long time and enjoy good brand recognition.

PROSPECTS

  • Over the forecast period, the medicated skin care category is predicted to grow at a 4% constant value CAGR, to reach GTQ58 million at constant 2010 prices. Acne treatments will be the main drivers of this category, accounting for 74% of total value sales in 2015. Sales in this category will benefit from the large young population (10-19 years) in the country, which by 2015 will account for 23% of the total Guatemalan population.

CATEGORY DATA

  • Table 52 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 53 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 54 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 55 Medicated Skin Care Brand Shares 2007-2010
  • Table 56 Hair Loss Treatments Brand Shares 2007-2010
  • Table 57 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 58 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Value sales of NRT smoking cessation aids reached GTQ4 million in 2010, up by 12% in terms of current value in that year. Sales of this category have been favoured by the passing by the Guatemalan Congress of a smoking ban, in February 2009. Following the passing of this law, it is illegal to smoke in any public place. This new law contributed to sales of NRT smoking cessation aids, with more people seeking to quit smoking. Individuals who break this law can be fined the equivalent of up to 10 minimum daily salaries, equating to approximately US$65, while companies which flout the law can be fined in the region of US$600-1,300, and even face the closure of the establishment.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Guatemala dominates the smoking cessation aids category, with an 85% value share in 2010. The company maintains its position through its brand Nicorette, which is available in gum and patch format.

PROSPECTS

  • A 5% constant value CAGR is predicted for the forecast period, to reach sales of GTQ4 million at constant 2010 prices by 2015. Although competing brands have not capitalised on the new smoking ban in the country, this law is expected to help boost sales of NRT smoking cessation aids. However, law enforcement in Guatemala is rather lax, and some studies made since the establishment of the ban reveal that many people do not comply with it. Nevertheless, in many areas of the country, especially in Guatemala City, smoking in public is increasingly seen as rude and is not as socially acceptable as it used to be, so many people could start to show an interest in quitting.

CATEGORY INDICATORS

  • Table 59 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 60 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 61 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 62 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 63 NRT Smoking Cessation Aids Company Shares 2006-2010
  • Table 64 NRT Smoking Cessation Aids Brand Shares 2007-2010
  • Table 65 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 66 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2009, sports nutrition registered value sales of GTQ15 million, up by 4% on 2009. Growth has been driven by a greater focus on fitness and physical appearance. Young men are the main consumers of these products, especially those who work out at gyms. Innovation and good quality have contributed to the consistent growth in this category.

COMPETITIVE LANDSCAPE

  • 71% of value sales of sports nutrition in 2010, were accounted for by GNC Guatemala SA, which has positioned itself as the expert in sports nutrition in the country. The company has been able to maintain its strong competitive position, having gained a reputation for good quality.

PROSPECTS

  • Sales of sports nutrition are predicted to grow at a 4% constant value CAGR over the forecast period, to reach GTQ18 million at constant 2010 prices. Sales of this still emerging category are expected to continue growing, helped by the expansion of gyms and increased health awareness. Higher disposable incomes among the younger population, thanks to the increase in employment in this age segment, are also expected to help the category grow.

CATEGORY DATA

  • Summary 9 Sports Nutrition: Brand Ranking By Format 2010
  • Table 67 Sales of Sports Nutrition: Value 2005-2010
  • Table 68 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 69 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 70 Sports Nutrition Company Shares 2006-2010
  • Table 71 Sports Nutrition Brand Shares 2007-2010
  • Table 72 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 73 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Guatemala - Category Analysis

HEADLINES

TRENDS

  • The vitamins and dietary supplements category experienced current value growth of 8% in 2010, to reach sales of GTQ189 million. The multivitamins category accounted for 48% of total value sales in that year. Products in this category are only consumed by middle-to-upper income consumers, who are able to afford them despite of their relatively high prices when compared to most Guatemalans’ disposable incomes.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • GNC Guatemala is the leading manufacturer in the category, with a 14% share of value sales in 2010. The company’s strong position is mainly due to its importance in the vitamins category, in which it accounts for 20% of total current value sales. The success of the company can be attributed to consistent marketing and advertising campaigns, as well as a strong reputation among heavy users of this type of product, especially thanks to the fact that the company offers specialised assessment.

PROSPECTS

  • Sales of vitamins and dietary supplements are predicted to grow at 3% constant value CAGR over the 2010-2015 period, with sales reaching GTQ223 million at constant 2010 prices. The potential for growth is still considerable, with a growing population, and a large percentage of young people in the country.

CATEGORY DATA

  • Summary 10 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 74 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 75 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 76 Dietary Supplements by Positioning 2006-2010
  • Table 77 Vitamins and Dietary Supplements Company Shares 2006-2010
  • Table 78 Vitamins and Dietary Supplements Brand Shares 2007-2010
  • Table 79 Vitamins Brand Shares 2007-2010
  • Table 80 Dietary Supplements Brand Shares 2007-2010
  • Table 81 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 82 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Weight management grew by 15% in terms of current value sales in 2010, to GTQ3 million. Weight loss supplements are the most important category, accounting for around 50% of total value sales. Weight management as a whole is still in the emerging stage in the Guatemalan market.

COMPETITIVE LANDSCAPE

  • Herbalife Guatemala is the leader in weight management, accounting for 47% of value sales in 2010. The company has been able to achieve this position thanks to its dominance in meal replacement slimming products.

PROSPECTS

  • Over the forecast period, weight management is expected to experience a 6% constant value CAGR, to reach GTQ4 million at constant 2010 prices by 2015. Growth in this category is expected to be boosted by increased health and beauty awareness among urban Guatemalan consumers. Growing obesity rates, which are expected to continue increasing due to lifestyle changes among urban population, will increase demand for slimming products.

CATEGORY DATA

  • Table 83 Sales of Weight Management by Category: Value 2005-2010
  • Table 84 Sales of Weight Management by Category: % Value Growth 2005-2010
  • Table 85 Weight Management Company Shares 2006-2010
  • Table 86 Weight Management Brand Shares 2007-2010
  • Table 87 Forecast Sales of Weight Management by Category: Value 2010-2015
  • Table 88 Forecast Sales of Weight Management by Category: % Value Growth 2010-2015

Wound Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2010, the wound care category in Guatemala grew by 7% in current value terms, to reach GTQ7 million. This category benefits significantly from the large percentage of young people in the population of Guatemala, as they represent the key consumer group for this type of product. The 42% of the population aged 0-14 years continues to be the main driver of sales of wound care products in the country.

COMPETITIVE LANDSCAPE

  • BDF Centroamérica SA led the wound care category in 2010, with a 66% share of value sales. 3M Guatemala SA followed, with a 12% share, while Algodón Superior held a share of 7%. The rest of the category is divided between a number of smaller brands. BDF Centroamérica SA and 3M Guatemala SA owe their strong positions to their brands Hansaplast and Nexcare, respectively, while Algodón Superior uses the company name as its brand.

PROSPECTS

  • The wound care category is expected to show a 3% constant value CAGR over the forecast period, to reach sales of GTQ8 million at constant 2010 prices by 2015. Sticking plasters/adhesive bandages are expected to account for 45% of total value sales in 2015, with gauze, tape and other wound care accounting for the remaining 55%. The high proportion of children and teenagers in the population, who are the key consumers of this type of product, will continue to favour growth in the category.

CATEGORY DATA

  • Table 89 Sales of Wound Care by Category: Value 2005-2010
  • Table 90 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 91 Wound Care Company Shares 2006-2010
  • Table 92 Wound Care Brand Shares 2007-2010
  • Table 93 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 94 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Child-Specific Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Child-Specific Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Child-Specific Consumer Health
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
          • Child-Specific Cough, Cold and Allergy Remedies
            • Child-Specific Allergy Remedies
            • Child-Specific Cough/Cold Remedies
          • Child-Specific Digestive Remedies
            • Child-Specific Diarrhoeal Remedies
            • Child-Specific Indigestion and Heartburn Remedies
            • Child-Specific Laxatives
            • Child-Specific Motion Sickness Remedies
          • Child-Specific Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Child-Specific Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices % growth
      • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices % growth
      • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices % growth
      • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices % growth
      • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      RELATED

      Consumer Lifestyle

      Future Demographic

      Country Report